Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing repaglinide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Repaglinide 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Repaglinide 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Repaglinide 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metformin hydrochloride 500 mg and repaglinide 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metformin hydrochloride 500 mg and repaglinide 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing metformin and repaglinide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Metformin hydrochloride 500 mg and repaglinide 2 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin hydrochloride 500 mg and repaglinide 1 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Repaglinide 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Repaglinide 500 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Repaglinide 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Repaglinide 1 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Repaglinide 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Repaglinide 2 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin hydrochloride 500 mg and repaglinide 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Metformin hydrochloride 500 mg and repaglinide 2 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Metformin hydrochloride 500 mg and repaglinide 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Metformin hydrochloride 500 mg and repaglinide 1 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Metformin hydrochloride 500 mg and repaglinide 2 mg oral tablet |
Has precise active ingredient |
False |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Repaglinide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Repaglinide 500 microgram oral tablet |
Has precise active ingredient |
True |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Repaglinide 1 mg oral tablet |
Has precise active ingredient |
True |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Repaglinide 2 mg oral tablet |
Has precise active ingredient |
True |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin hydrochloride 500 mg and repaglinide 1 mg oral tablet |
Has precise active ingredient |
False |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing metformin and repaglinide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Metformin and repaglinide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only repaglinide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Repaglinide only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only metformin and repaglinide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Metformin hydrochloride 500 mg and repaglinide 2 mg oral tablet |
Has precise active ingredient |
True |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Metformin hydrochloride 500 mg and repaglinide 1 mg oral tablet |
Has precise active ingredient |
True |
Repaglinide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |